Carag (Switzerland)

Carag (Switzerland), also known as CARAG AG, is a Swiss medical engineering company based in Baar, Switzerland. It operates at the intersection of medical device development, engineering consulting, and clinical research services. The company works with physicians, inventors, and medtech companies to turn ideas into market-ready products, offering expertise in areas such as medical technology, clinical and in-vivo studies, electrical and mechanical engineering, electronics and software, prototyping, testing, and marketing approval. Carag's business model is built on partnership: for physicians and inventors, it provides technical and personnel resources and finances development, allowing them to avoid financial risk while gaining direct access to engineers. For the medtech industry, it acts as a development partner, complementing internal teams and guiding projects through the regulatory landscape until market clearance. The company emphasizes Swiss precision, creativity, and state-of-the-art technology. Over the past 20 years, Carag has developed a range of devices and technologies. Its project portfolio includes an oxygenation monitoring system for preterm babies, a brain monitoring system, wound debridement devices (debritom + and DebriClip), a dental water jet for peri-implantitis therapy, aerosol propagation solutions (AeroGuard Nebbia and Jellyfish), high-pressure pumps, micro jet nozzle platforms, a bioresorbable septal occluder (reSept ASD occluder), arterial banding devices, and fluid collection systems. These projects reflect the company's focus on innovative, often minimally invasive or disposable medical solutions. Carag is a private company, not publicly listed. Its headquarters in Baar places it within the Swiss medtech ecosystem, and its services and products are aimed at both Swiss and international markets. The company's website and project pages highlight collaborations with clinicians and its role as a reliable industry partner in challenging medical fields such as congenital heart defects.

Carag (Switzerland), operating as CARAG AG, is a Swiss medical engineering company headquartered in Baar, Switzerland. While the exact founding year is not provided in the available evidence, the company's project page states that it has developed devices and technologies over the last 20 years, indicating a history spanning at least two decades in medical device innovation. The company was established to bridge the gap between clinical ideas and market-ready medical products. Its model centers on collaboration with physicians and inventors, providing them with technical and financial resources to develop their concepts without personal financial risk. This approach has led to a portfolio of projects in areas such as neonatology, neurology, wound care, dentistry, and cardiology. Over time, Carag has built expertise in medical technology, clinical and in-vivo studies, electrical and mechanical engineering, electronics and software, prototyping, testing, and regulatory affairs. It offers these services both to individual physicians and to the medtech industry, positioning itself as a flexible partner that can complement internal development teams. Notable projects include the reSept ASD occluder, described as the world's first septal occluder with a metal-free, bioresorbable framework; the Carag Brain Monitoring System; an oxygenation monitoring system for preterm babies; and the debritom + wound debridement device with its DebriClip accessory. Other developments include a dental water jet for peri-implantitis therapy, aerosol propagation solutions (AeroGuard Nebbia and Jellyfish), high-pressure pumps, micro jet nozzle platforms, arterial banding devices, and fluid collection systems. The company is based in Baar, in the canton of Zug, Switzerland, a region known for its business-friendly environment and concentration of medtech and life sciences companies. Carag remains a private company, not listed on any stock exchange. Its website and project pages highlight collaborations with clinicians, including testimonials from pediatric cardiologists in Zurich and Gothenburg, underscoring its role as an industry partner in challenging medical fields.

• Carag has developed devices and technologies over the last 20 years (as stated on its projects page).

Swiss medical engineering partner for physicians, inventors, and medtech companies, offering end-to-end development from concept to market clearance with Swiss precision.

• Oxygenation monitoring in preterms

  System to measure the oxygenation of the belly to prevent potentially severe complications in preterm babies.

• Carag Brain Monitoring System

  Multifunctional brain probe to provide reliable, safe and efficient measurement of key neurologic parameters.

• debritom +

  Wound debridement device that cleans acute and chronic wounds precisely and in a tissue-preserving manner.

• DebriClip

  Versatile accessory for debritom +.

• Dental water jet

  Dental water jet intended to be used for surgical peri-implantitis therapy.

• AeroGuard Nebbia and Jellyfish

  Propagation of aerosols during wound cleaning procedure.

• High pressure pumps

  Single use high pressure pump.

• Micro jet nozzles platform

  Platform of low cost micro jet nozzles for various applications.

• reSept ASD occluder

  World's first septal occluder with metal free, bioresorbable framework.

• Arterial banding

  Device for easy and controlled banding of the pulmonary arteries.

• Fluid collection

  Complete redesign of a disposable fluid collection system.

1. 1Home | CARAG AGcarag.com
2. 2Projects | CARAG AGcarag.com
3. 3Carag (Switzerland) - Wikidatawikidata.org